Cytokines and Sympathetic Activation in Heart Failure
Cytokines and Sympathetic Activation in Heart Failure
批准号:
8389884
负责人:
Robert B Felder
金额:
$35.34万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-07-01 至 2014-07-31
关键词:
AddressAdverse effectsAgeAmericasAngiotensin IIAngiotensinogenApoptosisArrhythmiaAutomobile DrivingBindingBinding ProteinsBloodBlood CirculationBrainBrain regionCardiacCardiovascular systemCerebrospinal FluidChronicClinicalClinical ResearchClinical TrialsCritiquesDataDinoprostoneDiseaseDoseEnzymesEtanerceptEtiologyEuropeExclusionFamilyGoalsHealedHealthHeartHeart failureHospitalizationHumanHypothalamic structureImmune systemIndustryInfectionInflammationInflammation MediatorsInflammatoryInflammatory ResponseInjuryInterventionInvestigationIschemiaKidneyLeft Ventricular FunctionLifeLiteratureLymphomaMediatingMediator of activation proteinMethodsModelingMolecularMorbidity - disease rateMyocardial dysfunctionNADPNF-kappa BNerveNeuraxisNeuronsNuclearOxidasesPatientsPericytesPeripheralPlasmaPopulationPreventive InterventionProcessProductionProsencephalonProstaglandinsProtein PrecursorsProteinsPublishingRattusReactive Oxygen SpeciesReceptor, Angiotensin, Type 1RegimenReninRenin-Angiotensin SystemResearchRoleSeverity of illnessSourceStimulusSuperoxidesSympathetic Nervous SystemSyndromeTNF geneTestingTherapeuticTherapeutic InterventionTissuesTumor Necrosis Factor-alphaUnited StatesWorkabstractingadverse outcomebrain tissuecyclooxygenase 2cytokinehealinghuman old age (65+)infliximabinsightmembermortalityneurochemistryneuromechanismnovelnovel strategiesparaventricular nucleusreceptorstatisticstranscription factorvasoconstriction
中文摘要
点击翻译按钮获取中文摘要
英文摘要
6. Project Summary/Abstract
Heart failure is the most common reason for hospitalization in the United States among those older than 65
years, and this statistic is expected to grow as the population ages. Overactivity of the sympathetic nervous
system is a cardinal manifestation of the heart failure syndrome, and a strong predictor of morbidity and
mortality. The etiology of increased sympathetic activity in heart failure is multifactorial. Recent studies have
implicated inflammatory mechanisms that generate reactive oxygen species, particularly activation of
nicotinamide adenine dinucleotide phosphate [NAD(P)H] oxidase dependent superoxide, in cardiovascular
regions of the brain. The ability of angiotensin II to generate superoxide and sympathetic drive by this
mechanism has been well studied - almost to the exclusion of other inflammatory mediators that are also
increased in heart failure and might well contribute. The present project examines the potential role of the pro-
inflammatory cytokines, which increase in plasma and brain of rats with ischemia-induced heart failure, are
capable of NAD(P)H oxidase driven superoxide production, and are known to contribute to increased
sympathetic drive in heart failure. We will test three hypotheses with regard to the mechanisms by which pro-
inflammatory cytokines might activate the sympathetic nervous system in a rat model of ischemia-induced
heart failure that mimics the most common form of heart failure in humans: 1) pro-inflammatory cytokines
increase sympathetic nerve activity in heart failure rats by inducing cyclooxygenase-2 activity and the
production of prostaglandin E2, which is sympatho-excitatory in the brain; 2) pro-inflammatory cytokines
increase sympathetic nerve activity in heart failure rats by upregulating the brain renin-angiotensin system and
the production of angiotensin II, which is sympatho-excitatory in the brain in its own right as well as by
stimulating superoxide production; and 3) pro-inflammatory cytokines directly stimulate NAD(P)H oxidase
dependent superoxide production. This project focuses upon the actions of pro-inflammatory cytokines in the
paraventricular nucleus of the hypothalamus, a forebrain cardiovascular regulatory center that has been
identified as an important source of the increased sympathetic nerve activity in heart failure. Neurochemical
changes in the paraventricular nucleus in heart failure, and the cellular and molecular mechanisms which
regulate them, will be investigated using molecular and immunohistochemical/immunofluorescent methods,
and the results of those studies will be correlated with functional data from electrophysiological studies
examining the effects of manipulating key putative mediators of sympathetic nerve activity. These studies will
identify currently unrecognized mechanisms driving the sympathetic nervous system in heart failure, and thus
potential targets for preventive intervention.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Brain MAP Kinases - Substrate for Sympathetic Excitation in Heart Failure
-
批准号:8204899
-
项目类别:
-
资助金额:$37.75万
-
财政年份:2010
-
负责人:Robert B Felder
-
依托单位:
Brain MAP Kinases - Substrate for Sympathetic Excitation in Heart Failure
-
批准号:8399052
-
项目类别:
-
资助金额:$35.94万
-
财政年份:2010
-
负责人:Robert B Felder
-
依托单位:
Brain MAP Kinases - Substrate for Sympathetic Excitation in Heart Failure
-
批准号:8038587
-
项目类别:
-
资助金额:$37.6万
-
财政年份:2010
-
负责人:Robert B Felder
-
依托单位:
Brain MAP Kinases - Substrate for Sympathetic Excitation in Heart Failure
-
批准号:8589602
-
项目类别:
-
资助金额:$37.0万
-
财政年份:2010
-
负责人:Robert B Felder
-
依托单位:
Cytokines and Sympathetic Activation in Heart Failure
-
批准号:8758110
-
项目类别:
-
资助金额:$37.75万
-
财政年份:2003
-
负责人:Robert B Felder
-
依托单位:
Cytokines and Sympathetic Activation in Heart Failure
-
批准号:6671631
-
项目类别:
-
资助金额:$46.25万
-
财政年份:2003
-
负责人:Robert B Felder
-
依托单位:
Cytokines and Sympathetic Activation in Heart Failure
-
批准号:8197258
-
项目类别:
-
资助金额:$37.13万
-
财政年份:2003
-
负责人:Robert B Felder
-
依托单位:
Cytokine and sympathetic drive in heart failure
-
批准号:6704843
-
项目类别:
-
资助金额:$5.0万
-
财政年份:2003
-
负责人:Robert B Felder
-
依托单位:
Cytokines and Sympathetic Activation in Heart Failure
-
批准号:7751935
-
项目类别:
-
资助金额:$37.5万
-
财政年份:2003
-
负责人:Robert B Felder
-
依托单位:
Cytokines and Sympathetic Activation in Heart Failure
-
批准号:6769972
-
项目类别:
-
资助金额:$45.06万
-
财政年份:2003
-
负责人:Robert B Felder
-
依托单位:
Cytokines and Sympathetic Activation in Heart Failure
-
批准号:7078626
-
项目类别:
-
资助金额:$44.0万
-
财政年份:2003
-
负责人:Robert B Felder
-
依托单位:
Cytokines and Sympathetic Activation in Heart Failure
-
批准号:7993587
-
项目类别:
-
资助金额:$37.5万
-
财政年份:2003
-
负责人:Robert B Felder
-
依托单位:
Cytokines and Sympathetic Activation in Heart Failure
-
批准号:6919119
-
项目类别:
-
资助金额:$45.06万
-
财政年份:2003
-
负责人:Robert B Felder
-
依托单位:
Cytokines and Sympathetic Activation in Heart Failure
-
批准号:7579352
-
项目类别:
-
资助金额:$37.5万
-
财政年份:2003
-
负责人:Robert B Felder
-
依托单位:
Cytokines and Sympathetic Activation in Heart Failure
-
批准号:9108419
-
项目类别:
-
资助金额:$37.75万
-
财政年份:2003
-
负责人:Robert B Felder
-
依托单位:
BRAIN STEM MECHANISMS MEDIATING THE NOCICEPTIVE PRESSOR RESPONSE
-
批准号:6564792
-
项目类别:
-
资助金额:$23.33万
-
财政年份:2002
-
负责人:Robert B Felder
-
依托单位:
HYPOTHALAMIC NEUROPEPTIDE PATHWAYS MEDIATING SYMPATHETIC RESPONSES TO LEPTIN
-
批准号:6564795
-
项目类别:
-
资助金额:$23.33万
-
财政年份:2002
-
负责人:Robert B Felder
-
依托单位:
HYPOTHALAMIC NEUROPEPTIDE PATHWAYS MEDIATING SYMPATHETIC RESPONSES TO LEPTIN
-
批准号:6415222
-
项目类别:
-
资助金额:$23.33万
-
财政年份:2001
-
负责人:Robert B Felder
-
依托单位:
BRAIN STEM MECHANISMS MEDIATING THE NOCICEPTIVE PRESSOR RESPONSE
-
批准号:6415219
-
项目类别:
-
资助金额:$23.33万
-
财政年份:2001
-
负责人:Robert B Felder
-
依托单位:
ANGIOTENSIN AND CENTRAL NEUROHUMORAL ACTIVATION IN CHF
-
批准号:6476905
-
项目类别:
-
资助金额:$33.08万
-
财政年份:2000
-
负责人:Robert B Felder
-
依托单位:
海外基金